Bosnalijek

What Bosnalijek does

Bosnalijek d.d. Sarajevo is the largest pharmaceutical manufacturer in Bosnia and Herzegovina, founded in 1951 and headquartered in Sarajevo with a workforce of 501-1000 employees. The company designs, manufactures, and distributes a broad portfolio of prescription medicines (Rx), over-the-counter products (OTC), food supplements, and consumer healthcare goods (including antiseptic solutions). Its therapeutic coverage spans cardiovascular, antiinfectives, musculoskeletal, nervous system, respiratory, dermatological, and alimentary/metabolic categories, with branded franchises such as Alerix, Lysobact, Rhinostop, DOLOREX, Enterofuryl STOP, Royal Jelly, D3 SPRAY, FeRAL, Apixa, Tozar, and Promass. Manufacturing is conducted under a quality assurance system aligned with national and international GMP standards, and the company operates from a single Sarajevo headquarters with ten regional representative offices across Southeast Europe (Albania, Montenegro, Croatia, Kosovo, Macedonia, Serbia) and Eastern Europe (Russia, Ukraine, Moldova), supplemented by a distribution partnership with FC Grand Capital in the Russian market.

Bosnalijek is publicly listed on the Sarajevo Stock Exchange (ticker: BSNLR) and operates a sales-led go-to-market model centered on pharmacy networks and healthcare providers. Its distribution channel is built on direct representative offices in 10 countries, brand-specific product websites, and a mobile application (Bosnalijek Vademaecum) for product information access. The company generates revenue from one-time sales of pharmaceutical products across Rx, OTC, food supplements, and consumer goods categories; pricing is not publicly disclosed. The overall business model is that of a regional branded generics manufacturer leveraging an entrenched domestic incumbent position, multi-jurisdiction regulatory compliance, and a portfolio of established consumer brands to serve healthcare providers and end consumers across the Balkans and select Eastern European markets.

Name

Bosnalijek

Legal name

Bosnalijek d.d. Sarajevo

Website

https://bosnalijek.com

Company type

Public

Founded year

1951

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Bosnalijek d.d. Sarajevo is the largest pharmaceutical manufacturer in Bosnia and Herzegovina, founded in 1951, producing generic prescription medicines, OTC drugs, food supplements, and consumer healthcare products distributed via 10 regional representative offices across the Balkans and Eastern Europe.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

Keywords

• Generic pharmaceuticals
• Prescription medicines
• OTC medications
• Food supplements
• Pharmaceutical manufacturing

Headquarters

HQ city

Sarajevo

HQ country

Bosnia & Herzegovina

HQ region

Europe

Offices10 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Revenue generated from manufacturing and selling prescription medicines (Rx), over-the-counter products (OTC), food supplements, and consumer goods (antiseptic solutions)

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Bosnalijek manufactures and distributes generic pharmaceutical products including prescription medicines (Rx), over-the-counter (OTC) products, food supplements, and consumer healthcare brands across therapeutic areas such as cardiovascular, musculoskeletal, antiinfectives, nervous system, respiratory, dermatological, and alimentary/metabolism. The company operates a single GMP-aligned production site in Sarajevo and supplies finished dose generics through representative offices in 10 countries.

Product overview

Bosnalijek is the largest industrial manufacturer of medicines in Bosnia and Herzegovina, established in 1951. The company operates as a pharmaceutical manufacturer producing generic medicines, dietary supplements, and consumer healthcare products. The product portfolio includes prescription medicines across therapeutic categories including cardiovascular system (beta blockers, calcium channel blockers, ACE inhibitors, lipid modifying agents, antithrombotic agents), antiinfectives for systemic use (antibacterials), musculoskeletal system (antigout preparations, drugs for bone diseases), nervous system (antipsychotics), respiratory system (antihistamines), alimentary tract and metabolism products, dermatologicals, and food supplements. Key prescription brands include ALOPURINOL BOSNALIJEK, AMLODIL, APIXA, AZOMEX, DUOCLAV, TOZAR, ALERIX, ANGINAL, and AMLOPRESSIN. Over-the-counter products include BOSPYRIN PROTECT, Enterofuryl STOP, Rhinostop, Lysobact, and DOLOREX. Dietary supplements include Royal Jelly, D3 SPRAY, and FeRAL. Consumer goods include antiseptic products like ALKOSOL and ASEPTAN. The company maintains a quality assurance system aligned with national and international GMP standards.

Differentiator

Problem solved

Functional benefit

Brands

• Royal Jelly®: Dietary supplement containing natural royal jelly in lyophilized form.
• Alerix®
• Enterofuryl STOP®
• Rhinostop®
• Lysobact®
• Fenix NEO®
• Lynase®
• DOLOREX®
• MECOBALAMIN
• D3 SPRAY®
• Lysoderm®
• Altioks®
• FeRAL®

Products and services

• ALOPURINOL BOSNALIJEK Generic prescription medicine in the musculoskeletal therapeutic category, used for conditions such as gout and hyperuricemia. Sold through Bosnalijek's pharmacy and wholesale distribution channels.
• ALTIOKS Generic prescription medicine in the alimentary/metabolism therapeutic category. Distributed through Bosnalijek's regional pharmacy and healthcare channels.
• AMINOL Generic prescription medicine in the cardiovascular therapeutic category. Distributed via Bosnalijek's representative offices and wholesale partners.
• AMLODIL Generic prescription medicine in the cardiovascular therapeutic category. Distributed through Bosnalijek's pharmacy network in B&H and regional markets.
• APIXA Generic prescription medicine in the cardiovascular therapeutic category. Distributed through Bosnalijek's regional distribution channels.
• AZOMEX Generic prescription medicine in the antiinfectives therapeutic category. Distributed through pharmacy and healthcare institution channels.
• BOSPYRIN PROTECT Generic prescription medicine in the cardiovascular therapeutic category. Distributed through Bosnalijek's pharmacy wholesale network.
• DUOCLAV Generic prescription medicine in the antiinfectives therapeutic category. Distributed through Bosnalijek's pharmacy and healthcare institution channels.
• LUMINEL Generic prescription medicine in the nervous system therapeutic category. Distributed through Bosnalijek's regional representative offices.
• OPSTILAX Food supplement product distributed through Bosnalijek's pharmacy retail channels.
• PROMASS Generic prescription medicine in the musculoskeletal therapeutic category. Distributed through Bosnalijek's pharmacy wholesale network.
• TOZAR Generic prescription medicine in the cardiovascular therapeutic category. Distributed through Bosnalijek's pharmacy and healthcare channels.
• ALERIX Generic prescription medicine in the respiratory therapeutic category, used in the treatment of allergic conditions. Distributed through Bosnalijek's regional pharmacy network.
• ALKOSOL Consumer healthcare product distributed through Bosnalijek's pharmacy retail channels.
• AMLOPRESSIN Generic prescription medicine in the cardiovascular therapeutic category. Distributed through Bosnalijek's pharmacy wholesale network.
• AMLOPRESSIN PLUS Generic prescription medicine in the cardiovascular therapeutic category, combination formulation. Distributed through Bosnalijek's pharmacy wholesale network.
• ANGINAL Generic prescription medicine in the cardiovascular therapeutic category. Distributed through Bosnalijek's pharmacy and healthcare institution channels.
• ARGEDIN Generic prescription medicine in the dermatological therapeutic category. Distributed through Bosnalijek's pharmacy wholesale network.
• ASEPTAN Consumer healthcare product distributed through Bosnalijek's pharmacy retail channels.
• Royal Jelly Branded food supplement positioned for nutritional supplementation, marketed through a dedicated brand website. Sold through Bosnalijek's pharmacy retail channels.
• Enterofuryl STOP OTC product for gastrointestinal symptoms, positioned for consumer self-medication. Distributed through Bosnalijek's pharmacy retail channels.
• Rhinostop OTC product for symptomatic relief of cold and respiratory symptoms, positioned for consumer self-medication. Distributed through Bosnalijek's pharmacy retail channels.
• Lysobact OTC product positioned for consumer self-medication of throat and upper respiratory symptoms. Distributed through Bosnalijek's pharmacy retail channels.
• Fenix NEO Branded consumer healthcare product supported by a dedicated brand website. Distributed through Bosnalijek's pharmacy retail channels.
• Lynase Product in the respiratory therapeutic category. Distributed through Bosnalijek's pharmacy retail channels.
• Rhinostop HOT OTC product for symptomatic relief of cold and respiratory symptoms, positioned for consumer self-medication. Distributed through Bosnalijek's pharmacy retail channels.
• MECOBALAMIN Food supplement product distributed through Bosnalijek's pharmacy retail channels.
• D3 SPRAY Branded vitamin D3 food supplement positioned for consumer use. Distributed through Bosnalijek's pharmacy retail channels.
• DOLOREX Generic prescription medicine in the nervous system therapeutic category for pain management. Distributed through Bosnalijek's pharmacy and healthcare channels.
• Lysoderm Product in the dermatological therapeutic category. Distributed through Bosnalijek's pharmacy retail channels.
• FeRAL Food supplement product distributed through Bosnalijek's pharmacy retail channels.

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• FC Grand CapitalcoreChannel Partner/ Reseller/ DistributorFC Grand Capital is described as one of the leading distribution partners on the Russian market. The partnership strengthens international cooperation with Bosnalijek hosting employees from its Russia representative office along with representatives of FC Grand Capital.

Scale indicators2 records

Recent moves5 records

Expansion highlights10 records

Direct peers

• Alvogen: Alvogen is a privately held generics and specialty pharma company with manufacturing and sales across CEE, CIS and Asia; its regional generic distribution model and emerging-markets emphasis position it as a directly comparable peer to Bosnalijek's Balkan/CIS-focused generics business.
• KRKA: KRKA (Slovenia) is a Central European generic pharmaceutical manufacturer with a regional sales footprint across the Balkans and CIS — directly comparable to Bosnalijek's business model as a multi-therapeutic generic producer selling through pharmacies and tenders in overlapping geographies.
• Hemofarm: Hemofarm (Serbia) is a leading Serbian pharmaceutical manufacturer (STADA-owned) producing generics and consumer health products for the Balkans and beyond — a directly comparable regional generic-pharma peer with overlapping therapeutic categories.
• Gedeon Richter: Gedeon Richter (Hungary) is a CEE-based pharmaceutical company with a large generics business plus branded women's health and CNS franchises; comparable to Bosnalijek's regional manufacturing footprint, Rx/OTC mix, and Balkans/CIS commercial reach.
• Polpharma: Polpharma is one of the largest pharmaceutical manufacturers in Central/Eastern Europe, producing generics, OTC products and APIs in Poland; comparable to Bosnalijek's large-scale regional generic manufacturing plus multi-therapeutic portfolio across CEE markets.
• Zentiva: Zentiva is a pan-European generics manufacturer headquartered in Prague that, like Bosnalijek, focuses on affordable off-patent medicines distributed widely across Central, Eastern and Southeastern European markets — making it a closely matched generic-pharma peer.

Regional players

• Galenika: Galenika is a Serbian state-affiliated pharmaceutical manufacturer producing Rx generics, OTC products and dietary supplements for the domestic and broader Balkan market — a strong regional peer to Bosnalijek's closest geographic neighbour competitor.

Broad incumbents

• Sandoz: Sandoz, the Novartis generics spin-off, is a global leader in off-patent medicines with established pan-Balkan presence; serves as a broad incumbent peer, competing with Bosnalijek in CEE tenders and OTC categories at meaningfully larger scale.
• Teva Pharmaceutical Industries: Teva is the world's largest generic medicines company with a wide-ranging generics and specialty portfolio and a global commercial network; a broad incumbent peer against which Bosnalijek's regional-generic business is benchmarked, especially in Balkan tenders.
• STADA Arzneimittel: STADA is a large European generics and consumer healthcare group with broad therapeutic coverage across CEE and Western Europe; serves as a broader incumbent analogue to Bosnalijek, with overlapping molecules and OTC categories but a much wider geographic scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/bosnalijekbih
• LinkedInlinkedin.com/company/bosnalijek-bih

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bosnalijek